LifeCore Biomed (LCBM) Reports Earnings
LifeCore Biomed (Nasdaq: LCBM) reported Q3 EPS of $0.09 , cents better than the analysts estimates $0.08. Revenues for the quarter were $15.7 million, versus the consensus of $16 million. It maintains full year year 2008.
Lifecore Biomedical, Inc. (Lifecore), incorporated in 1965, manufactures biomaterials and medical devices for use in various surgical markets.
Lifecore Biomedical, Inc. (Lifecore), incorporated in 1965, manufactures biomaterials and medical devices for use in various surgical markets.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Mentor Graphics Corp (MENT) Beats Q1 EPS View by 5c; Lifts FY13 Outlook
- Taro Pharmaceutical Industries (TARO) Nearly Doubles Q1 EPS to 1.06
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
